164 related articles for article (PubMed ID: 2443836)
1. Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments.
Nilsson B; Svensson KE; Borwell P; Nilsson UR
Mol Immunol; 1987 May; 24(5):487-94. PubMed ID: 2443836
[TBL] [Abstract][Full Text] [Related]
2. Distinctive expression of neoantigenic C3(D) epitopes on bound C3 following activation and binding to different target surfaces in normal and pathological human sera.
Nilsson B; Ekdahl KN; Svensson KE; Bjelle A; Nilsson UR
Mol Immunol; 1989 Apr; 26(4):383-90. PubMed ID: 2469949
[TBL] [Abstract][Full Text] [Related]
3. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
4. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
Garred P; Mollnes TE; Lea T; Fischer E
Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
[TBL] [Abstract][Full Text] [Related]
6. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.
Nilsson B; Nilsson Ekdahl K; Avila D; Nilsson UR; Lambris JD
Biochem J; 1990 May; 268(1):55-61. PubMed ID: 1693076
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
8. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
9. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
10. Preparation of monoclonal antibodies to C3b by immunization with C3b(i)-sepharose.
Tosic L; Sutherland WM; Kurek J; Edberg JC; Taylor RP
J Immunol Methods; 1989 Jun; 120(2):241-9. PubMed ID: 2786912
[TBL] [Abstract][Full Text] [Related]
11. An assessment of the extent of antigenic analogy between physiologically bound C3 and C3 denatured by sodium dodecyl sulphate.
Nilsson B; Nilsson UR
Scand J Immunol; 1985 Dec; 22(6):703-10. PubMed ID: 2418495
[TBL] [Abstract][Full Text] [Related]
12. Antibodies with specificity for native and denatured forms of ovalbumin differ in reactivity between enzyme-linked immunosorbent assays.
Holm BE; Bergmann AC; Hansen PR; Koch C; Houen G; Trier NH
APMIS; 2015 Feb; 123(2):136-45. PubMed ID: 25470666
[TBL] [Abstract][Full Text] [Related]
13. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
Iida K; Mitomo K; Fujita T; Tamura N
J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
[TBL] [Abstract][Full Text] [Related]
14. Complement fragments C3b and iC3b coupled to latex induce a respiratory burst in human neutrophils.
Hoogerwerf M; Weening RS; Hack CE; Roos D
Mol Immunol; 1990 Feb; 27(2):159-67. PubMed ID: 2138709
[TBL] [Abstract][Full Text] [Related]
15. Quantification by ELISA of erythrocyte-bound C3 fragments expressing C3d and/or C3c epitopes in patients with factor I deficiency and with autoimmune diseases.
Møller Rasmussen J; Jepsen HH; Teisner B; Holmskov-Nielsen U; Rasmussen GG; Svehag SE
Vox Sang; 1989; 56(4):262-9. PubMed ID: 2474900
[TBL] [Abstract][Full Text] [Related]
16. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
Baatrup G; Svehag SE; Jensenius JC
Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
[TBL] [Abstract][Full Text] [Related]
17. Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3.
Palarasah Y; Skjodt K; Brandt J; Teisner B; Koch C; Vitved L; Skjoedt MO
J Immunol Methods; 2010 Oct; 362(1-2):142-50. PubMed ID: 20869965
[TBL] [Abstract][Full Text] [Related]
18. Characterization of three monoclonal antibodies against C3 with selective specificities.
Iida K; Mitomo K; Fujita T; Tamura N
Immunology; 1987 Nov; 62(3):413-7. PubMed ID: 2444528
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies Against C3b-Functional Consequences and Disease Relevance.
Vasilev VV; Radanova M; Lazarov VJ; Dragon-Durey MA; Fremeaux-Bacchi V; Roumenina LT
Front Immunol; 2019; 10():64. PubMed ID: 30761135
[TBL] [Abstract][Full Text] [Related]
20. Specificity of three anti-complement factor 3 monoclonal antibodies.
Henwick S; Hetherington SV; Hostetter MK
J Immunol Methods; 1992 Aug; 153(1-2):173-84. PubMed ID: 1517587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
